Speaker illustration

Professor Vincent Maher

Tallaght University Hospital, Dublin (Ireland)

Where are we with cholesterol busting and the use of PCSK9 inhibitors.

Event: EuroHeartCare 2018

Topic: Risk Factors and Prevention

Session: Addressing risk factors - Primary to secondary prevention

Thumbnail

This platform is supported by

logo Novo Nordisk